BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock, offered at a price to the public of $15.50 per share. The gross proceeds to Seattle Genetics from this offering are expected to be $155,000,000, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Seattle Genetics. Seattle Genetics has granted the underwriters a 30-day option to purchase up to an aggregate of 1,500,000 additional shares of common stock to cover overallotments, if any. All of the shares in the offering are to be sold by Seattle Genetics. The offering is expected to close on or about February 7, 2011, subject to customary closing conditions.
